<code id='EE0F4FB969'></code><style id='EE0F4FB969'></style>
    • <acronym id='EE0F4FB969'></acronym>
      <center id='EE0F4FB969'><center id='EE0F4FB969'><tfoot id='EE0F4FB969'></tfoot></center><abbr id='EE0F4FB969'><dir id='EE0F4FB969'><tfoot id='EE0F4FB969'></tfoot><noframes id='EE0F4FB969'>

    • <optgroup id='EE0F4FB969'><strike id='EE0F4FB969'><sup id='EE0F4FB969'></sup></strike><code id='EE0F4FB969'></code></optgroup>
        1. <b id='EE0F4FB969'><label id='EE0F4FB969'><select id='EE0F4FB969'><dt id='EE0F4FB969'><span id='EE0F4FB969'></span></dt></select></label></b><u id='EE0F4FB969'></u>
          <i id='EE0F4FB969'><strike id='EE0F4FB969'><tt id='EE0F4FB969'><pre id='EE0F4FB969'></pre></tt></strike></i>

          Home / entertainment / explore

          explore


          explore

          author:fashion    Page View:34
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In